GlassScriptPhysician profile
Sergio R Cisneros
NPI 1174257521
$1,298.31
in general payments reported to CMS, 2019-2025
14 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $267 · 2023: $365 · 2024: $242 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $233.17 | 2022-2025 | Cequa |
| Harrow Eye, LLC | $145.19 | 2024-2025 | Vevye |
| Dompe US, INC. | $139.71 | 2025 | Oxervate |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Abbvie INC. | $114.70 | 2023-2024 | Alphagan P, Lumigan, Vuity |
| Oyster Point Pharma, INC. | $106.02 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $89.23 | 2024 | |
| Bausch & Lomb Americas INC. | $75.90 | 2023-2025 | Miebo, Vyzulta |
| Alcon Vision LLC | $68.71 | 2023-2024 | Simbrinza |
| Tarsus Pharmaceuticals, INC. | $67.11 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $45.68 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Thea Pharma INC. | $44.90 | 2023 | Iyuzeh |
| Horizon Therapeutics Plc | $22.76 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $20.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Cisneros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.